my understanding is that they bought APD for the client base - particularly in Asia where they are doing very well. Whether this converts to the bottom line, time will tell.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025